Behavioral medicine in HIV infection;Verhaltensmedizin bei HIV-infektion

Psychotherapeut

Volumn 48, Issue 5, 2003, Pages 342-347

  Schneiderman, N ^a   Antoni, M H ^b   Ironson, G ^b  

^a Department of Biology   (United States)

^b NONE

Author keywords

Cognitive behavioral stress management; Endocrines Viral load; HIV Aids; Immune status; Mood

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; HYDROCORTISONE; NORADRENALIN; TESTOSTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANXIETY DISORDER; ARTICLE; BEHAVIOR MEDICINE; BEHAVIOR THERAPY; COGNITIVE BEHAVIOR STRESS MANAGEMENT; CYTOTOXIC T LYMPHOCYTE; DISTRESS SYNDROME; DYSPHORIA; HELPER CELL; HERPES SIMPLEX VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; IMMUNE STATUS; IMMUNE SYSTEM; MENTAL STRESS; MOOD DISORDER; NORADRENALIN BLOOD LEVEL; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TESTOSTERONE BLOOD LEVEL; VIRUS LOAD;

EID: 0141995755     PISSN: 09356185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00278-003-0328-z     Document Type: Article

References (15)

1. Antoni HM, Baggett L, Ironson G et al. (1991) Cognitive behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol 59:906-915
2. Antoni HM, Cruess SE, Cruess DG et al. (2000a) Cognitive behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med 22:29-37
3. Antoni MH, Cruess DG, Cruess SE et al. (2000b) Cognitive behavioral stress management intervention effects on anxiety, 24-hour urinary norepinephrine output, and T-cytotoxics/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol 68:31-45
4. Antoni MH, Cruess DG, Klimas N et al. (2002) Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: Effects on transitional naive T-cells. Amer J Psychiatr 159:143-145
5. Belkin GS, Fleishman JA, Stein MD, Piette J, Mor V (1992) Physical symptoms among individuals with HIV infection. Psychosom 33:416-427
6. Cruess DG, Antoni MH, Schneiderman N et al. (2000) Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men. Health Psychol 19:12-20
7. Esterling BA, Antoni MH, Schneiderman N, Ironson G, La Periere A, Klimas N, Fletcher MA (1992) Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and herpes virus type-6 in HIV-1 infected and at-risk gay men. Psychosom Med 54:354-371
8. Ironson G, Freidman A, Klimas N et al. (1994) Distress, denial, and low adherence to behavioral interventions predict faster disease progression in HIV-1 infected gay men. Int J Behav Med 1:90-105
9. Lutgendorf S, Antoni MH, Ironson G et al. (1997) Cognitive behavioral stress management decreases dysphoric mood and herpes simplex virus type2 antibody titers in symptomatic HIV-seropositive gay men. J Consult Clin Psychol 65:31-43
10. Lutgendorf S, Antoni MH, Ironson G et al. (1998) Changes in cognitive coping skills and social support mediate distress outcomes in symptomatic HIV-seropositive gay men during a cognitive behavioral stress management intervention. Psychosom Med 60:204-214
11. Malow RM, McPherson S, Klimas N et al. (1998) Adherence to complex combination antiretrovital therapies in HIV-drug abusers. Psychiatr Serv 49:1021-1024
12. McPherson-Baker S, Malow RM, Penedo F, Jones DL; Schneiderman N (2000) Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. Aids Care 12:399-404
13. McPherson-Baker S, Jones D, Duran R, Klimas N, Schneiderman N (2003) Development and implementation of a medication adherence training instrument (MATI) for people living with HIV. Behav Modification (in press)
14. Montagnier L, Gruest S, Chamaret C (1984) Adaptation of lymphoadenopathy associated virus (LAV) to replication in EBV-transformed B-lymphoblastoid cell lines. Science 226:63-66
15. Paterson D, Swindell S, Mohr J et al. (1999) How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMS caps. 6th Conference on Retroviruses and Opportunistic Infections, p 6